Prothena Corp PLC (PRTA)
48.88
+0.76 (+1.58%)
USD |
NASDAQ |
Mar 29, 12:28
Prothena Max Drawdown (5Y): 90.85% for Feb. 28, 2023
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
February 28, 2023 | 90.85% |
January 31, 2023 | 90.85% |
December 31, 2022 | 90.85% |
November 30, 2022 | 90.85% |
October 31, 2022 | 90.85% |
September 30, 2022 | 90.85% |
August 31, 2022 | 90.85% |
July 31, 2022 | 90.85% |
June 30, 2022 | 90.85% |
May 31, 2022 | 90.85% |
April 30, 2022 | 90.85% |
March 31, 2022 | 90.85% |
February 28, 2022 | 90.85% |
January 31, 2022 | 90.85% |
December 31, 2021 | 90.85% |
November 30, 2021 | 90.85% |
October 31, 2021 | 90.85% |
September 30, 2021 | 90.85% |
August 31, 2021 | 90.85% |
July 31, 2021 | 90.85% |
June 30, 2021 | 90.85% |
May 31, 2021 | 90.85% |
April 30, 2021 | 90.85% |
March 31, 2021 | 90.85% |
February 28, 2021 | 90.85% |
Date | Value |
---|---|
January 31, 2021 | 90.85% |
December 31, 2020 | 90.85% |
November 30, 2020 | 90.85% |
October 31, 2020 | 90.85% |
September 30, 2020 | 90.85% |
August 31, 2020 | 90.85% |
July 31, 2020 | 90.85% |
June 30, 2020 | 90.85% |
May 31, 2020 | 90.85% |
April 30, 2020 | 90.85% |
March 31, 2020 | 90.85% |
February 29, 2020 | 90.85% |
January 31, 2020 | 90.85% |
December 31, 2019 | 90.85% |
November 30, 2019 | 90.85% |
October 31, 2019 | 90.85% |
September 30, 2019 | 90.85% |
August 31, 2019 | 90.85% |
July 31, 2019 | 88.41% |
June 30, 2019 | 88.41% |
May 31, 2019 | 88.41% |
April 30, 2019 | 88.41% |
March 31, 2019 | 88.41% |
February 28, 2019 | 88.41% |
January 31, 2019 | 88.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
64.26%
Minimum
Mar 2018
90.85%
Maximum
Aug 2019
89.36%
Average
90.85%
Median
Aug 2019
Max Drawdown (5Y) Benchmarks
Mallinckrodt PLC | -- |
Jazz Pharmaceuticals PLC | 54.54% |
Nabriva Therapeutics PLC | 99.91% |
Iterum Therapeutics PLC | -- |
GH Research PLC | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 5.768 |
Beta (5Y) | 0.4153 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.19% |
Historical Sharpe Ratio (5Y) | 0.6543 |
Historical Sortino (5Y) | 1.554 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.53% |